Oumar Camara

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Michael Untch, Peter A. Fasching, Gottfried E. Konecny et al. · Journal of Clinical Oncology · 2011 · 508 citations

Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse

Katharina Pachmann, Oumar Camara, Andreas Kavallaris et al. · Journal of Clinical Oncology · 2008 · 280 citations

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Jürgen Veeck, Dieter Niederacher, Han‐Xiang An et al. · Oncogene · 2006 · 254 citations

Tumor Biology, Aberrant Methylation, Breast Oncology +10

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Katharina Pachmann, Joachim H. Clement, Claus-Peter Schneider et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2005 · 150 citations

Application of MR Mammography Beyond Local Staging: Is There a Potential to Accurately Assess Axillary Lymph Nodes? Evaluation of an Extended Protocol in an Initial Prospective Study

Pascal Baltzer, Matthias Dietzel, H Burmeister et al. · American Journal of Roentgenology · 2011 · 136 citations